Cart
sales@molnova.com
Sulfaproxiline
CAS No. 116-42-7
Sulfaproxiline( Sulfaproxylin | Sulfaproxyline | Sulphaproxyline )
Catalog No. M26469 CAS No. 116-42-7
Sulfaproxiline is a synthetic antibacterial drug of sulfonamide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 39 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 155 | In Stock |
|
| 100MG | 231 | In Stock |
|
| 200MG | 343 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSulfaproxiline
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfaproxiline is a synthetic antibacterial drug of sulfonamide.
-
DescriptionSulfaproxiline is a synthetic antibacterial drug of sulfonamide.
-
In Vitro——
-
In Vivo——
-
SynonymsSulfaproxylin | Sulfaproxyline | Sulphaproxyline
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number116-42-7
-
Formula Weight334.39
-
Molecular FormulaC16H18N2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)Oc1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bruno O, Brullo C, Arduino N, Schenone S, Ranise A, Bondavalli F, Ottonello L, Dapino P, Dallegri F. Synthesis and biological evaluation of neutrophilic inflammation inhibitors. Farmaco. 2004 Mar;59(3):223-35.
molnova catalog
related products
-
KKL-10
KKL-10 is a small-molecule inhibitor of bacterial ribosome rescue that exhibits broad-spectrum antimicrobial activity against bacteria grown in liquid culture.
-
Maleic acid
Maleic Acid is a Glutamate Decarboxylase (GAD) inhibitor of E. coli and L. monocytogenes.
-
Ceforanide
Ceforanide is a second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall.
